The HeartFlow FFRCT Analysis is the first non-invasive diagnostic tool that aids clinicians in determining, vessel by vessel, both the extent of an artery’s narrowing and the impact that the narrowing has on blood flow to the heart.
By non-invasively identifying which patients do and do not need intervention, clinicians can reduce unnecessary invasive testing, reduce healthcare system costs and improve patient quality of life.
The National Institute for Health and Care Excellence (NICE) provides national guidance and quality standards to improve health and social care within the UK’s National Health Service (NHS).
NICE issued a Technology Assessment (MTG32) in February 2017 endorsing the use of the HeartFlow® FFRCT Analysis to help physicians determine the cause of stable chest pain in patients. This guidance follows the Chest Pain Guidelines (CG95) issued in November 2016, recommending non-invasive coronary CT angiography (CTCA) as the initial diagnostic test for patients with stable chest pain.
In April 2021, NICE released an updated review of MTG32 which found the following:
Don't see a listing in your area? Submit a request, and we'll try to bring the HeartFlow Analysis closer to you.
* Required fields